Production (Stage)
Carisma Therapeutics, Inc.
CARM
$0.4297
-$0.0219-4.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.59M | 18.83M | 28.13M | 41.91M | 58.06M |
| Total Receivables | -- | 2.86M | -- | 2.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 717.00K | 340.00K | 504.00K | 725.00K | 2.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.65M | 1.79M | 5.50M | 6.09M | 771.00K |
| Total Current Assets | 13.95M | 23.83M | 34.14M | 50.72M | 60.95M |
|
|
|||||
| Total Current Assets | 13.95M | 23.83M | 34.14M | 50.72M | 60.95M |
| Net Property, Plant & Equipment | 2.00M | 6.43M | 7.71M | 8.48M | 12.70M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 208.00K | 208.00K | 142.00K | 142.00K |
| Total Assets | 15.95M | 30.46M | 42.06M | 59.34M | 73.80M |
|
|
|||||
| Total Accounts Payable | 3.25M | 2.08M | 1.73M | 2.03M | 2.17M |
| Total Accrued Expenses | 4.71M | 7.45M | 4.54M | 9.24M | 4.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.64M | 1.74M | 2.46M | 2.46M | 3.86M |
| Total Finance Division Other Current Liabilities | 853.00K | 4.79M | 1.83M | 1.88M | 2.38M |
| Total Other Current Liabilities | 853.00K | 4.79M | 1.83M | 1.88M | 2.38M |
| Total Current Liabilities | 10.45M | 16.06M | 10.56M | 15.62M | 13.14M |
|
|
|||||
| Total Current Liabilities | 10.45M | 16.06M | 10.56M | 15.62M | 13.14M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 687.00K | 744.00K | 857.00K | 1.30M | 3.63M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 41.48M | 41.57M | 41.77M | 42.07M | 46.13M |
| Total Liabilities | 52.62M | 58.37M | 53.18M | 58.98M | 62.90M |
|
|
|||||
| Common Stock & APIC | 278.18M | 277.67M | 276.82M | 275.60M | 274.98M |
| Retained Earnings | -314.85M | -305.58M | -287.94M | -275.24M | -264.08M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -36.66M | -27.91M | -11.13M | 360.00K | 10.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.66M | -27.91M | -11.13M | 360.00K | 10.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.66M | -27.91M | -11.13M | 360.00K | 10.90M |
|
|
|||||